newsCollaboration to develop the world’s first prophylactic gonorrhoea vaccine25 August 2020 | By Hannah Balfour (European Pharmaceutical Review)Therapyx and Intravacc will jointly develop NGoXIM, a microsphere vaccine which is designed to stimulate adaptive immunity against gonorrhoea.